Loading clinical trials...
Loading clinical trials...
A Single-Arm, Multicenter Phase IIIB Clinical Trial to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
Conditions
Interventions
Emicizumab
Locations
72
Australia
Royal Prince Alfred Hospital; Haematology
Camperdown, New South Wales, Australia
Alfred Hospital
Melbourne, Victoria, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
UZ Leuven Gasthuisberg
Leuven, Belgium
Centro de Hematologia E Hemoterapia Do Parana - Hemepar
Curitiba, Paraná, Brazil
Instituto Estadual de Hema
Rio de Janeiro, Rio de Janeiro, Brazil
Start Date
September 5, 2017
Primary Completion Date
November 19, 2020
Completion Date
November 19, 2020
Last Updated
June 11, 2021
NCT07226206
NCT05987449
NCT04645199
NCT06703606
NCT06702579
NCT03818763
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions